David Dowling | Assistant Professor of Pediatrics, Harvard Medical School; Precision Vaccine Program, Division of Infectious Diseases
Boston Children's Hospital

Using Adjuvant Science to shape the future of human health – The AIDD (Adjuvant Innovation, Discovery, and Development) Laboratory, led by Dr. David Dowling at Boston Children's Hospital and Harvard Medical School, pioneers adjuvant-centric approaches to enhance vaccine efficacy in vulnerable populations, such as infants and the elderly, where age-specific immune responses often limit protection. Our research elucidates mechanistic innate and adaptive immunity in a population-tailored manner, leveraging adjuvant discovery, synergy evaluations, and class comparisons to inform rational vaccine design - distinct from traditional antigen-focused strategies.Using Adjuvant Science to shape the future of human health..